Benitec Biopharma (BNTC) Change in Account Payables (2019 - 2025)
Historic Change in Account Payables for Benitec Biopharma (BNTC) over the last 7 years, with Q2 2025 value amounting to -$5.2 million.
- Benitec Biopharma's Change in Account Payables fell 43959.82% to -$5.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$2.4 million, marking a year-over-year decrease of 35270.99%. This contributed to the annual value of -$2.4 million for FY2025, which is 35270.99% down from last year.
- Per Benitec Biopharma's latest filing, its Change in Account Payables stood at -$5.2 million for Q2 2025, which was down 43959.82% from $3.8 million recorded in Q1 2025.
- In the past 5 years, Benitec Biopharma's Change in Account Payables ranged from a high of $3.8 million in Q1 2025 and a low of -$5.2 million during Q2 2025
- Over the past 5 years, Benitec Biopharma's median Change in Account Payables value was $533000.0 (recorded in 2022), while the average stood at $82888.9.
- Its Change in Account Payables has fluctuated over the past 5 years, first soared by 37694.81% in 2021, then crashed by 46650.79% in 2024.
- Quarter analysis of 5 years shows Benitec Biopharma's Change in Account Payables stood at $853000.0 in 2021, then crashed by 164.48% to -$550000.0 in 2022, then skyrocketed by 307.45% to $1.1 million in 2023, then crashed by 157.67% to -$658000.0 in 2024, then crashed by 696.35% to -$5.2 million in 2025.
- Its Change in Account Payables was -$5.2 million in Q2 2025, compared to $3.8 million in Q1 2025 and -$658000.0 in Q4 2024.